Literature DB >> 11854695

Mitochondrial function during ischemic preconditioning.

Juan A Crestanello1, Nicolai M Doliba, Andriy M Babsky, Natalia M Doliba, Koki Niibori, Mary D Osbakken, Glenn J R Whitman.   

Abstract

Background. Ischemic preconditioning (IPC) protects the myocardium from ischemia reperfusion injury. The effect of IPC on the mitochondria is not well known. However, one of the mechanisms postulated in IPC (the opening of the mitochondrial K(ATP) channels) is likely to result in changes in mitochondrial function. Therefore, the purpose of this study was to determine the effect of IPC on mitochondrial function during ischemia reperfusion. Methods. Isolated rat hearts (n = 6/group) were subjected to (1) 30 minutes of equilibration, 25 minutes of ischemia, and 30 minutes of reperfusion (RP) (control group) or (2) 10 minutes of equilibration, two-5 minute episodes of IPC (each followed by 5 minutes of re-equilibration), 25 minutes of ischemia, and 30 minutes of RP (IPC group). Left ventricular rate pressure product (RPP) was measured. At end-equilibration (end-EQ) and at end-reperfusion (end-RP) mitochondria were isolated. Mitochondrial respiratory function (state 2, 3, and 4), respiratory control index (RCI), rate of oxidative phosphorylation (ADP/Delta t), and ADP:O ratio were measured by polarography with the use of NADH- or FADH-dependent substrates. Results. IPC improved recovery of RPP at end-RP (72% +/- 5% in IPC vs 30% +/- 4% in control, P <.05). Ischemia reperfusion (IR) decreased state 3, ADP/Delta t, and RCI in both groups compared with end-EQ. IPC improved state 3 (47 +/- 3 in IPC vs 37 +/- 2 ng-atoms O/min/mg protein in control), ADP/Delta t (17 +/- 1 in IPC vs 13 +/- 1 nmol/s/mg protein in control), and RCI (3.7 +/- 0.1 in IPC vs 2.1 +/- 0.2 in control) at end-RP compared with control with the use of NADH-dependent substrate (P <.05 vs control). IPC also improved state 3 (85 +/- 6 in IPC vs 71 +/- 4 ng-atoms O/min/mg protein in control), ADP/Delta t (18 +/- 2 in IPC vs 12 +/- 1 nmol/s/mg protein in control), RCI (2 +/- 0.1 in IPC vs 1.5 +/- 0.1 in control), and ADP:O ratios (1.4 +/- 0.04 in IPC vs 1.7 +/- 0.09 in control) at end-RP compared with control with the use of FADH-dependent substrate (P <.05 vs control). Conclusions. The cardioprotective effects of IPC can be attributed at least in part to the preservation of mitochondrial function during reperfusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854695     DOI: 10.1067/msy.2002.119490

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

1.  Ischemic preconditioning decreases mitochondrial proton leak and reactive oxygen species production in the postischemic heart.

Authors:  Ricardo Quarrie; Brandon M Cramer; Daniel S Lee; Gregory E Steinbaugh; Warren Erdahl; Douglas R Pfeiffer; Jay L Zweier; Juan A Crestanello
Journal:  J Surg Res       Date:  2010-10-13       Impact factor: 2.192

2.  MitoK(ATP)-dependent changes in mitochondrial volume and in complex II activity during ischemic and pharmacological preconditioning of Langendorff-perfused rat heart.

Authors:  Philippe Pasdois; Bertrand Beauvoit; Liliane Tariosse; Béatrice Vinassa; Simone Bonoron-Adèle; Pierre Dos Santos
Journal:  J Bioenerg Biomembr       Date:  2006-09-21       Impact factor: 2.945

3.  Ischemic preconditioning preserves mitochondrial membrane potential and limits reactive oxygen species production.

Authors:  Ricardo Quarrie; Daniel S Lee; Gregory Steinbaugh; Brandon Cramer; Warren Erdahl; Douglas R Pfeiffer; Jay L Zweier; Juan A Crestanello
Journal:  J Surg Res       Date:  2012-06-17       Impact factor: 2.192

Review 4.  Mitochondria as a drug target in ischemic heart disease and cardiomyopathy.

Authors:  Andrew M Walters; George A Porter; Paul S Brookes
Journal:  Circ Res       Date:  2012-10-12       Impact factor: 17.367

Review 5.  Regulated production of free radicals by the mitochondrial electron transport chain: Cardiac ischemic preconditioning.

Authors:  Satoshi Matsuzaki; Pamela A Szweda; Luke I Szweda; Kenneth M Humphries
Journal:  Adv Drug Deliv Rev       Date:  2009-08-26       Impact factor: 15.470

6.  Protective effect of Momordica charantia water extract against liver injury in restraint-stressed mice and the underlying mechanism.

Authors:  Yuanyuan Deng; Qin Tang; Yan Zhang; Ruifen Zhang; Zhencheng Wei; Xiaojun Tang; Mingwei Zhang
Journal:  Food Nutr Res       Date:  2017-07-13       Impact factor: 3.894

7.  The valosin-containing protein is a novel mediator of mitochondrial respiration and cell survival in the heart in vivo.

Authors:  Paulo Lizano; Eman Rashed; Shaunrick Stoll; Ning Zhou; Hairuo Wen; Tristan T Hays; Gangjian Qin; Lai-Hua Xie; Christophe Depre; Hongyu Qiu
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

Review 8.  Cardioprotection in right heart failure.

Authors:  Kerstin Boengler; Klaus-Dieter Schlüter; Ralph Theo Schermuly; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2020-03-09       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.